Procter & Gamble Q1 2027 Earnings Analysis

More earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, joined as always by Jordan, and today we're digging into Procter & Gamble's fiscal Q1 2027 results — reported October 22nd. Before we dive in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. **JORDAN:** And honestly, Alex, this is a fun one. P&G doesn't usually give us "volume up 2.4%, organic sales up 4%" headlines — that's the kind of growth they haven't posted together since like 2022. **ALEX:** Exactly. Let's set the scene. Organic sales grew 4.0% — and this is the first quarter they're reporting that number to one decimal place, by the way, a small disclosure change. Volume contributed 2.4 points of that growth, pricing added 0.4 points, and mix added over a point. The headline here is that this is volume-led growth, not price-led. **JORDAN:** Which matters a lot right now. In this consumer environment, growing because more people are buying your stuff — not just because you raised prices — that's the better kind of growth story. **ALEX:** All ten product categories grew. All six geographic regions grew. North America was up 3%, Europe up 4% with the UK leading at high-single-digits, and Greater China was the standout at 8% growth, driven by SK-II up 12% and Pampers up nearly 50%. **JORDAN:** That Pampers number in China is wild, but CFO Andre Schulten was upfront that it's partly benefiting from a competitor stumbling in that market. Take out that tailwind and China's still growing mid-single-digits organically, which on its own is a great result given how soft Chinese consumer sentiment has been. **ALEX:** Now let's talk bottom line. Core EPS came in at $2.00, up about 1% year-over-year, flat on a currency-neutral basis. Gross margin was actually down 150 basis points, operating margin down 80 basis points. **JORDAN:** And here's the tension in this quarter — productivity improved a strong 250 basis points, but that got eaten up by rising commodity costs, freight, and continued marketing investment. Schulten flagged that commodity headwinds are only going to get worse from here. **ALEX:** Right, let's talk about that number because it's a big one — $1.4 billion after-tax commodity cost headwind for the full fiscal year. That's tied to oil, assuming Brent crude around $100 a barrel. And when you add in currency headwinds, higher interest expense from recent M&A, and lower non-operating income, the total headwind below the operating line balloons to about $1.9 billion after tax, or $0.79 a share — that's 11% of last year's core EPS. **JORDAN:** And what's notable is they only felt about 5% of that commodity hit in Q1, with 8% guided for the full year. So Schulten was basically telling investors: brace for Q2, because that's when the bigger chunk of this flows through the income statement. **ALEX:** Speaking of guidance — despite all that cost pressure, P&G held its full-year guidance ranges. Organic sales growth of 1% to 3%, though they're clearly running ahead of that right now. Core EPS growth of 0% to 3%, landing between $6.89 and $7.11 a share. They did raise the all-in GAAP sales outlook, but that's just to reflect the Thorne acquisition, which closed in early October. **JORDAN:** Thorne is interesting — that's the wellness and supplements brand. Management was clear on the call that they want Thorne's existing team to keep leading the business, with P&G playing a supporting role on things like international expansion and supply chain, not a full-on integration. **ALEX:** They also reaffirmed free cash flow productivity guidance of 85-90%, and plan to re This episode includes AI-generated content.